Navigation Links
Anaheim to Host World's Largest Cystic Fibrosis Medical Meeting
Date:9/27/2007

More than 3,000 leading scientists and clinicians to present advances in CF research and care

ANAHEIM, Calif., Sept. 27 /PRNewswire-USNewswire/ --- An international medical meeting will draw more than 3,000 cystic fibrosis experts from all fields of science and medicine to Anaheim Oct. 3 - 6, 2007 to present the latest information and advances in cystic fibrosis drug research and care.

The 21st annual North American Cystic Fibrosis Conference is an annual ritual for leading CF research scientists and clinicians to collaborate in an open and noncompetitive environment. Key topics will include:

-- Advancements in drug discovery and development and the importance of

clinical trials;

-- Aztreonam lysine for inhalation as a potential new CF therapy;

-- Quality improvement and patient outcomes;

-- The importance of newborn screening; and

-- Serving the Hispanic CF population in the U.S.

Cystic fibrosis is a life-threatening genetic disease that affects approximately 30,000 children and adults in the United States. Ten million people are unknowing carriers of a CF gene. Fifty years ago, most children with CF died before reaching elementary school. Today, because of Cystic Fibrosis Foundation-supported drug research and care, people with CF are living to a median predicated age of 37.

WHAT: The 21st Annual North American Cystic Fibrosis Conference, the largest international gathering of leading cystic fibrosis research scientists and clinicians.

WHEN & WHERE:

Wed., Oct. 3 - Sat., Oct. 6, 2007 at the Anaheim Convention Center, Anaheim, Calif.

PLENARY SESSION HIGHLIGHTS:

-- Thursday, Oct. 4, 4:20 p.m. - "From Basic Science to the Clinic: Where

Are We & What Is Still Missing?" Margarida D. Amaral, Ph.D.,

University of Lisbon, Lisbon, Portugal.

-- Friday, Oct. 5, 8:30 a.m. - "CF Drug Development: What's New?" Felix

Ratjen, M.D., Ph.D., The Hospital for Sick Children, Toronto, Ontario.

-- Sat., Oct. 6, 9:00 a.m. - "Improving Patient Outcomes Using the Tools

We Have Now" Michael Boyle, M.D., The Johns Hopkins Hospital,

Baltimore, Maryland.

INTERVIEWS AVAILABLE WITH:

Plenary speakers and other leading CF research scientists and clinicians

Robert J. Beall, Ph.D., President and CEO, Cystic Fibrosis Foundation

Preston W. Campbell, M.D., Executive Vice President for Medical Affairs, Cystic Fibrosis Foundation

About the Cystic Fibrosis Foundation

The Cystic Fibrosis Foundation is the leading organization devoted to curing and controlling cystic fibrosis. Headquartered in Bethesda, Md., the Foundation funds CF research, has 80 chapter and branch offices throughout the country, and supports and accredits a nationwide network of 115 CF care centers, which provide vital treatments and other CF resources to patients and families. For more information, visit http://www.cff.org.


'/>"/>
SOURCE Cystic Fibrosis Foundation
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Benefits Of The Worlds Most Widely Used Beverage
2. Worlds Largest Cord Blood Bank to be started in India
3. Australian Surgeons Successfully Conduct Worlds First Triple Organ Transplant
4. Worlds first mobile light surgery
5. Spanish Doctors Performs Worlds First Hand Transplantation Successfully
6. Worlds Heaviest Man Loses Weight Thanks to Monitored Dieting
7. Abu Dhabi to Have Worlds First Zero-carbon City
8. Eddie Murphy Voted Worlds Biggest Love-Rat
9. 3 die, 500 sickened in nations largest hepatitis A outbreak Associated Press
10. India Has The Oldest And Largest Collection Of Preserved Mosquitoes – Mosquito Museu
11. Heart Related Problems-The Largest Killers In Andhra Pradesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... 04, 2016 , ... Trinity Health today launched its inaugural ... aimed at improving care and reducing readmission rates for patients who are dually ... Health is to drive innovation that transforms our ministry and our industry to ...
(Date:5/4/2016)... SCOTTSDALE, AZ (PRWEB) , ... May 04, 2016 ... ... 2016 Annual Technology & Business Conference. The conference opened on Tuesday with Frank ... panel discussion on NCPDP’s PDMP Solution provided a deep dive on NCPDP’s model ...
(Date:5/4/2016)... ... ... Level 10 Head Over Heels Athletic Arts’ gymnast Alessandra Brovedani -- who goes ... fall of 2019. , After a handful of college visits, the Berkeley High ... her connection with the coaching staff and the excitement surrounding Wildcat Athletics. , “What ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... therapy products, announced today the introduction of the innovative newly improved Iso-Hip Wrap. ... hip replacement patients. The plush design enhances comfort and enables the patient to ...
(Date:5/4/2016)... , ... May 04, 2016 , ... Nike Rugby Camp's ... rugby in San Diego. Willis, founder of Elite Rugby Camps and current Nike Camp ... players every year since 2009. , “I’m excited for our eighth summer here ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it is ... a video of two patients who tell their personal story and encourage those at risk ... Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
(Date:5/3/2016)... May 3, 2016  Forté Elements, LLC (Forté) is excited to announce the launch ... address the nutritional needs of recovery for a variety of clinical conditions. Founded in ... Photo - http://photos.prnewswire.com/prnh/20160502/362548 Logo -  http://photos.prnewswire.com/prnh/20160502/362547LOGO ... ... ...
(Date:5/2/2016)...  Deerfield announced today it led the $44.5 ... Graybug Vision is an early stage pharmaceutical company ... for ocular diseases including wet age-related macular degeneration ... developed at Johns Hopkins University and has been ... Graybug Vision is developing ophthalmology products enabling ...
Breaking Medicine Technology: